Royalty Pharma Plc (RPRX)
Royalty Pharma Market Cap : 20.84B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Zymeworks, Inc. | 1.907B |
| Johnson & Johnson | 582.73B |
| Biogen, Inc. | 25.11B |
| Revolution Medicines, Inc. | 19.73B |
| Cytokinetics, Inc. | 8.233B |
Market Cap Related Metrics
| PE Ratio | 27.28 |
| PS Ratio | 10.87 |
| Price to Book Value | 3.213 |
| Price to Free Cash Flow | 28.81 |
| Price | 48.57 |
| Earnings Yield | 3.67% |
| Operating PE Ratio | 16.58 |
| Normalized PE Ratio | 28.14 |